- Home
- KBDC vs OPK Comparison
KBDC vs OPK Comparison
Compare KBDC & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBDC
- OPK
- Stock Information
- Founded
- KBDC 2021
- OPK 2007
- Country
- KBDC United States
- OPK United States
- Employees
- KBDC N/A
- OPK N/A
- Industry
- KBDC
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- KBDC
- OPK Health Care
- Exchange
- KBDC Nasdaq
- OPK Nasdaq
- Market Cap
- KBDC 1.1B
- OPK 1.1B
- IPO Year
- KBDC N/A
- OPK 1995
- Fundamental
- Price
- KBDC $15.27
- OPK $1.19
- Analyst Decision
- KBDC Buy
- OPK Buy
- Analyst Count
- KBDC 4
- OPK 4
- Target Price
- KBDC $16.50
- OPK $2.75
- AVG Volume (30 Days)
- KBDC 131.2K
- OPK 2.8M
- Earning Date
- KBDC 08-11-2025
- OPK 07-31-2025
- Dividend Yield
- KBDC 12.44%
- OPK N/A
- EPS Growth
- KBDC N/A
- OPK N/A
- EPS
- KBDC N/A
- OPK N/A
- Revenue
- KBDC N/A
- OPK $664,029,000.00
- Revenue This Year
- KBDC $193.84
- OPK N/A
- Revenue Next Year
- KBDC $12.68
- OPK $6.98
- P/E Ratio
- KBDC N/A
- OPK N/A
- Revenue Growth
- KBDC N/A
- OPK N/A
- 52 Week Low
- KBDC $13.93
- OPK $1.11
- 52 Week High
- KBDC $17.99
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- KBDC N/A
- OPK 29.73
- Support Level
- KBDC N/A
- OPK $1.34
- Resistance Level
- KBDC N/A
- OPK $1.38
- Average True Range (ATR)
- KBDC 0.00
- OPK 0.06
- MACD
- KBDC 0.00
- OPK -0.02
- Stochastic Oscillator
- KBDC 0.00
- OPK 23.53
About KBDC Kayne Anderson BDC Inc. Common Stock
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.